Journal ArticleDOI
The national high blood pressure education program.
About:
This article is published in Journal of the American Pharmaceutical Association.The article was published on 1974-04-01. It has received 1110 citations till now. The article focuses on the topics: Health education.read more
Citations
More filters
Journal ArticleDOI
Neonatal blood pressure regulation.
John E. Jones,Pedro A. Jose +1 more
TL;DR: In healthy neonates, systolic blood pressure increases rapidly during the first 6 weeks of life with the most rapid rise observed during the second 5 days, and a similar pattern is observed for diastolic pressures.
Journal ArticleDOI
Arterial hypertension following renal transplantation in children-a short-term study.
Samantha Santiago Nagasako,Paulo Cesar Koch Nogueira,Paula Goulart Pinheiro Machado,José Osmar Medina Pestana +3 more
TL;DR: The sole factor showing a statistically significant association with arterial hypertension was the GFR at 3 and 6 months after transplantation, which remains unclear to us as to whether this means the etiology of hypertension differs in children, or if this is the result of a bias in patient selection.
Journal ArticleDOI
Candesartan Cilexetil Effectively Reduces Blood Pressure in Hypertensive Children
TL;DR: Cedesartan cilexetil effectively reduced BP as demonstrated by CBPM and ABPM measurements and was well tolerated in this group of hypertensive children.
Proceedings Article
Integrating a modern knowledge-based system architecture with a legacy VA database: the ATHENA and EON projects at Stanford.
Aneel A. Advani,Samson W. Tu,Martin J. O'Connor,Robert W. Coleman,Mary K. Goldstein,Mark A. Musen +5 more
TL;DR: A new database mediator is described that affords the EON system both physical and logical data independence from the legacy VA database and requires two separate mapping levels and must itself involve a knowledge-based component.
Journal ArticleDOI
Monitoring Adherence to Medication by Measuring Change in Blood Pressure
TL;DR: Monitoring blood pressure is poor at detecting nonadherence to blood pressure-lowering treatment, and a secondary analysis of the Perindopril Protection Against Recurrent Stroke Study to look at other methods of assessing adherence.